Tag Archives: Dr Jean-Marc Guettier

US FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes

Washington: The US Food and Drug Administration has approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , | Leave a comment

US FDA approves Basaglar, the first “follow-on” insulin glargine product to treat diabetes

Washington: The US Food and Drug Administration on Wednesday approved Basaglar (insulin glargine injection), a long-acting human insulin analogue to improve glycaemic control in adult and paediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

Posted in NEWS, Pharmaceuticals | Tagged , , , , | Leave a comment

US FDA approves two new drug treatments for diabetes mellitus

Washington: The US Food and Drug Administration has approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec / insulin aspart injection) to improve blood sugar (glucose) control in adults with diabetes mellitus.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , | Leave a comment